Certified Global Research Member

Key Questions Answered

Global Market Outlook
In-depth analysis of global and regional trends
Analyze and identify the major players in the market, their market share, key developments, etc.
To understand the capability of the major players based on products offered, financials, and strategies.
Identify disrupting products, companies, and trends.
To identify opportunities in the market.
Analyze the key challenges in the market.
Analyze the regional penetration of players, products, and services in the market.
Comparison of major playersâ€™ financial performance.
Evaluate strategies adopted by major players.
Recommendations

Why Choose Market Research Future?

Vigorous research methodologies for specific market.
Knowledge partners across the globe
Large network of partner consultants.
Ever-increasing/ Escalating data base with quarterly monitoring of various markets
Trusted by fortune 500 companies/startups/ universities/organizations
Large database of 5000+ markets reports.
Effective and prompt pre- and post-sales support.

Celiac Disease Treatment Companies

Celiac Disease Treatment companies are dedicated to addressing the unique needs of individuals with celiac disease. Specializing in research and development, they offer innovative treatments and products that support gluten-free lifestyles, improving the management and well-being of those affected by this autoimmune condition.

Celiac Disease Treatment Key Companies

Latest Celiac Disease Treatment Companies Update:

Chugai Pharmaceutical Published promising results from a non-clinical study on DONQ52, a medication targeting the immune response to gluten without affecting the whole immune system. A phase 1 clinical trial is ongoing.

Topas Therapeutics Their phase 2a clinical trial for TPM502, an antigen-specific nanoparticle therapy for celiac disease, is underway. This therapy aims to induce immune tolerance towards gluten.

Alnylam Pharmaceuticals Announced positive preliminary results from a phase 1b study of lumasiran for celiac disease. Lumasiran targets a specific gene involved in the immune response to gluten.

ImmusanT This clinical-stage biotech company is developing ITM-15, a potential first-in-class T-cell therapy for celiac disease. They announced the initiation of a phase 1b/2a clinical trial in December 2023.

List of Celiac Disease Treatment Key companies in the market

General Mills Inc.

Innovate Biopharmaceutical

ActoBio

Glenmark Pharmaceuticals Company Ltd.

Takeda Pharmaceuticals Company Ltd.

Zydus Pharmaceuticals Inc.

BioLineRx

West-Ward Pharmaceuticals Company Ltd.

Calypso Biotech SA

Celiac Disease Treatment Market Highlights:

Celiac Disease Treatment Market Size

Celiac Disease Treatment Market Trends

Celiac Disease Treatment Market Analysis

Celiac Disease Treatment Market Share

Celiac Disease Treatment Market Highlights:

Celiac Disease Treatment Market Trends

Celiac Disease Treatment Market Analysis

Celiac Disease Treatment Market Share

Celiac Disease Treatment Companies

Leading companies partner with us for data-driven Insights

Kindly complete the form below to receive a free sample of this Report

Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
	Single User	$ 4,950
	Multiuser License	$ 5,950
	Enterprise User	$ 7,250
Compare Licenses

Tailored for You

Dedicated Research on any specifics segment or region.
Focused Research on specific players in the market.
Custom Report based only on your requirements.
Flexibility to add or subtract any chapter in the study.
Historic data from 2014 and forecasts outlook till 2040.
Flexibility of providing data/insights in formats (PDF, PPT, Excel).
Provide cross segmentation in applicable scenario/markets.